Crossmark

Comparison of reversal of rocuronium-induced neuromuscular blockade with sugammadex under remimazolam versus propofol anesthesia: a randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s00540-025-03517-7

Published Online: 2025-05-26

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kawasaki, Takashi

Fujimoto, Masafumi https://orcid.org/0000-0003-3153-9941
Hirata, Naoyuki
Funding

Funding for this research was provided by:

Kumamoto University
License Information

Text and Data Mining valid from 2025-05-26

Version of Record valid from 2025-05-26
More Information

Article History

Received: 7 April 2025

Accepted: 9 May 2025

First Online: 26 May 2025

Declarations

:

: T. Kawasaki has no conflict of interest; M. Fujimoto has received speaker’s fees from MSD Inc, Century Medical Inc, and Nihon Kohden Corporation. However, none of these entities provided financial support for his participation in this study; N. Hirata has received honoraria and speaker’s fees from Mundipharma, Maruishi Pharmaceutical Corporation, and Nihon Kohden Corporation. However, none of these entities provided financial support for his participation in this study. He has also received speaker’s fees from Asahi Kasei Corporation and Otsuka Pharmaceutical Factory.

Document is current

Any future updates will be listed below